Click on image to view larger version.

Figure 3 Hyperemic MBF in Placebo and Pioglitazone Groups at Baseline and After Treatment

After treatment, a significant increase in hyperemic myocardial blood flow (MBF) was observed in the pioglitazone group. Error bars indicate SEM. *p < 0.05 within-treatment effect.